SAM
APRE icon

Sectoral Asset Management’s Aprea Therapeutics APRE Stock Holding History

Sectoral Asset Management’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,184
Closed -$805K – 117
2020
Q4 		$805K Sell
8,184
-37,600
-82% -$17.9M 0.06% 87
2020
Q3 		$22M Hold
45,784
– – 1.89% 19
2020
Q2 		$35.5M Sell
45,784
-27,733
-38% -$18.2M 3.26% 1
2020
Q1 		$51.1M Hold
73,517
– – 9.81% 1
2019
Q4 		$67.5M Buy
+73,517
New +$40.5M 10.07% 1

Other funds holding APRE

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Sectoral Asset Management's APRE Position: Q1 2021 in Review

Sectoral Asset Management sold out of Aprea Therapeutics (APRE) in Q1 2021, closing a stake of 8,184 shares — an estimated $805K sold.

Sectoral Asset Management first reported a position in APRE in Q4 2019 and held it in 5 quarters. The position peaked at $67.5M in Q4 2019. 67 funds tracked by Wall St. Rank hold APRE as of Q1 2021.

  • Sectoral Asset Management reported no remaining Aprea Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Sectoral Asset Management sold 8,184 Aprea Therapeutics shares in Q1 2021, an estimated $805K.
  • Sectoral Asset Management first reported a position in Aprea Therapeutics in Q4 2019 and held it in 5 quarters.
  • Sectoral Asset Management's Aprea Therapeutics position peaked at $67.5M in Q4 2019.
  • 67 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2021.

Based on Sectoral Asset Management's 13F filing for Q1 2021, filed 14 May 2021.